Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue sup2
Submit an article Journal homepage
317
Views
19
CrossRef citations to date
0
Altmetric
Articles

Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping

Martin S. TallmanMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USACorrespondence[email protected]
Pages 65-68 | Published online: 04 Apr 2011

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Iman Abou Dalle & Farhad Ravandi. (2019) Moxetumomab pasudotox for the treatment of relapsed and/or refractory hairy cell leukemia. Expert Review of Hematology 12:9, pages 707-714.
Read now
Zheng Z Topp & Alan Saven. (2014) Hairy cell leukemia: a ‘hair-raising’ update. Expert Review of Hematology 7:5, pages 659-669.
Read now
Estella Matutes. (2013) Orphan drugs for the treatment of hairy cell leukemia. Expert Opinion on Orphan Drugs 1:1, pages 21-31.
Read now
Jae H Park & Martin S Tallman. (2011) Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible?. Expert Review of Hematology 4:4, pages 427-436.
Read now

Articles from other publishers (15)

Tadeusz Robak & Paweł Robak. (2022) Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance. Frontiers in Oncology 12.
Crossref
Raheel Siddiqui, Muhammad Sardar, Moazzam Shahzad, Jemin Jose, Insija Selene, Zunaira Shah, Anum Qureshi, Madeeha Shafqat, Rimsha Kashif, Maheen Ahmad, Alex Mejia-Garcia & Faiz Anwer. (2021) Management of Relapsed Hairy Cell Leukemia: A Systematic Review of Novel Agents and Targeted Therapies. Clinical Lymphoma Myeloma and Leukemia 21:10, pages 659-666.
Crossref
Connie Kang. (2021) Moxetumomab Pasudotox in Hairy Cell Leukaemia: A Profile of Its Use. Clinical Drug Investigation 41:9, pages 829-834.
Crossref
Mark B. Geyer, Omar Abdel-Wahab, Martin S. Tallman & Jae H. Park. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1872 1883.e5 .
Damond Barrick Ng, Gary Schiller & Edward Ha. (2019) Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib. Annals of Hematology 98:10, pages 2443-2445.
Crossref
Karen M Fancher & Zachary C Lally-Montgomery. (2019) Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia. Journal of Oncology Pharmacy Practice 25:6, pages 1467-1472.
Crossref
Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E. Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotic, Loree Larratt, Fritz Offner, Gary Schiller, Ronan Swords, Larry Bacon, Monica Bocchia, Krimo Bouabdallah, Dimitri A. Breems, Agostino Cortelezzi, Shira Dinner, Michael Doubek, Bjorn Tore Gjertsen, Marco Gobbi, Andrzej Hellmann, Stephane Lepretre, Frederic Maloisel, Farhad Ravandi, Philippe Rousselot, Mathias Rummel, Tanya Siddiqi, Tamar Tadmor, Xavier Troussard, Cecilia Arana Yi, Giuseppe Saglio, Gail J. Roboz, Kemal Balic, Nathan Standifer, Peng He, Shannon Marshall, Wyndham Wilson, Ira Pastan, Nai-Shun Yao & Francis Giles. (2018) Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia. Leukemia 32:8, pages 1768-1777.
Crossref
Francesca Guerrini, Matteo Paolicchi, Francesco Ghio, Elena Ciabatti, Susanna Grassi, Serena Salehzadeh, Giacomo Ercolano, Maria R. Metelli, Marzia Del Re, Lorenzo Iovino, Iacopo Petrini, Giovanni Carulli, Nadia Cecconi, Martina Rousseau, Giulia Cervetti & Sara Galimberti. (2016) The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia. Frontiers in Pharmacology 7.
Crossref
S. Dietrich, M. Andrulis & T. Zenz. (2015) HaarzellleukämieHairy cell leukemia. Der Internist 56:4, pages 381-390.
Crossref
Justin M. Watts & Martin S. Tallman. 2014. Cancer Consult: Expertise for Clinical Practice. Cancer Consult: Expertise for Clinical Practice 220 225 .
Michael R. Grever, James S. Blachly & Leslie A. Andritsos. (2014) Hairy cell leukemia: Update on molecular profiling and therapeutic advances. Blood Reviews 28:5, pages 197-203.
Crossref
Jae H. Park & Martin S. Tallman. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1979 1990.e4 .
Robert J. Kreitman. (2012) Immunoconjugates and new molecular targets in hairy cell leukemia. Hematology 2012:1, pages 660-666.
Crossref
Enrico TiacciGianluca SchiavoniFrancesco ForconiAlessia SantiLivio TrentinAchille AmbrosettiDebora CecchiniElisa SozziPaola Francia di Celle, Cristiana Di Bello, Alessandro Pulsoni, Robin Foà, Giorgio Inghirami & Brunangelo Falini. (2012) Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 119:1, pages 192-195.
Crossref
Konnie M. Hebeda, Patricia J. T. A. Groenen & J. Han van Krieken. 2012. Bone Marrow Lymphoid Infiltrates. Bone Marrow Lymphoid Infiltrates 83 95 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.